New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 10.5 mg/ml (4% overage);  ;   - solution for injection - 50 mg/5ml - active: calcium folinate 10.5 mg/ml (4% overage)     excipient: sodium chloride water for injection - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired. use in combination with 5-fluorouracil in the treatment of advanced colorectal carcinoma.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 18.6mg equivalent to folinic acid 15 mg - tablet - 15 mg - active: calcium folinate 18.6mg equivalent to folinic acid 15 mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired.

Irland - engelsk - HPRA (Health Products Regulatory Authority)

hospira uk limited - calcium folinate - solution for injection - 10 mg/ml - detoxifying agents for antineoplastic treatment

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - calcium folinate is one of the b group of vitamins. calcium folinate injection is used to reduce the side effects of other medicines (a group of medicines called folic acid antagonists). examples of folic acid antagonists are: ? methotrexate (a medicine often used to treat cancer). ? trimetrexate (an antibiotic and anti-cancer medicine) ? trimethoprim (an antibiotic) ? pyrimethamine (a medicine often used to treat malaria) it may also be used to treat an overdose of these medicines. calcium folinate injection may also be used to increase the effectiveness of the anti-cancer medicine fluorouracil. in combination with 5-fluorouracil in cytotoxic therapy for progressive colorectal cancer

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - calcium folinate hydrate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection - excipient ingredients: sodium hydroxide; sodium chloride; hydrochloric acid; water for injections - calcium folinate is one of the b group of vitamins. calcium folinate injection is used to reduce the side effects of other medicines (a group of medicines called folic acid antagonists). examples of folic acid antagonists are: ? methotrexate (a medicine often used to treat cancer) ? trimetrexate (an antibiotic and anti-cancer medicine) the treatment of megaloblastic anaemias due to sprue, nutritional deficiency, pregnancy, infancy, liver disease and malabsorption syndrome when oral therapy is not possible. ? trimethoprim (an antibiotic) ? pyrimethamine (a medicine often used to treat malaria) it may also be used to treat an overdose of these medicines.calcium folinate injection may also be used to increase the effectiveness of the anti-cancer medicine fluorouracil. for use in combination with fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - calcium folinate, quantity: 11.34 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - calcium folinate is one of the b group of vitamins. calcium folinate injection is used to reduce the side effects of other medicines (a group of medicines called folic acid antagonists). examples of folic acid antagonists are: ? methotrexate (a medicine often used to treat cancer) ? trimetrexate (an antibiotic and anti-cancer medicine) ? trimethoprim (an antibiotic) ? pyrimethamine (a medicine often used to treat malaria). it may also be used to treat an overdose of these medicines. calcium folinate injection may also be used to increase the effectiveness of the anti-cancer medicine fluorouracil.

Irland - engelsk - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - folinic acid - solution for injection - 10 milligram(s)/millilitre - detoxifying agents for antineoplastic treatment; calcium folinate

Malta - engelsk - Medicines Authority

cherubino limited - calcium folinate 15 mg - tablet

USA - engelsk - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c: calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown.

USA - engelsk - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate tablets contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. a c